The patient journey from symptom onset to pacemaker implantation

QJM: An International Journal of Medicine

Volumn 101, Issue 12, 2008, Pages 955-960

  Cunnington, Mike S ^a   Plummer, C J ^a   Mcdiarmid, A K ^a   Mccomb, J M ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBSERVATIONAL STUDY; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HOSPITAL; SYMPTOM; TREATMENT INDICATION; UNITED KINGDOM;

EID: 57049090423     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn122     Document Type: Article

References (9)

1. Ector H, Vardas P. Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: Data from the registry of the European Heart Rhythm Association. Eur Heart J 2007; 9(Suppl. I):I44-9.
2. Network Devices Survey Group. Pacemakers and implantable defibrillators: UK National Survey 2006-2007; [http://www.ic.nhs.uk/webfiles/Services/ NCASP/Heart/reports/National%20Report%202006%20version%202.1% 20SUMMARY.pdf] (accessed June 25 2008).
3. McComb JM, Plummer CJ, Charles R, Cunningham M, Cunningham A. Inequity of access to cardiac pacing: Results of a national survey (abstract). Heart 2007; 93(Suppl. 1):A46.
4. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices - summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to update the 1998 pacemaker guidelines). J Am Coll Cardiol 2002; 40 1703-19.
5. Mackintosh A, Boyle R. Reasons for delay in permanent pacemaker insertion. J R Coll Physicians 1986; 20:220-1.
6. Zeltzer D, Justo D, Halkin A, Rosso R, Ish-Shalom M, Hochenberg M, et al. Drug-induced atrioventricular block: Prognosis after discontinuation of the culprit drug. J Am Coll Cardiol 2004; 44 105-8.
7. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51 e1-62. [http://content.onlinejacc.org/cgi/content/full/ j.jacc.2008.02.032] (accessed June 25 2008).
8. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy. Europace. 2007; 9:959-98. [http://www.escardio.org/guidelines-surveys/esc-guidelines/ GuidelinesDocuments/guidelines-cardiac-pacing-ES.pdf] Last accessed 25th June 2008.
9. ACC/AHA pocket guideline: Device-based therapy of cardiac rhythm abnormalities. 2008; [http://www.acc.org/qualityandscience/clinical/ guidelines/dbt/DBT_Pocket_Guide.pdf] (accessed June 25 2008).